Testing effectiveness (Phase 2)Looking for participantsNCT07165847
What this trial is testing
Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and GE-junction Cancer : A Randomized, Two-arm, Prospective Trial (TRIUNITE-05)
Who this might be right for
ImmunotherapyGastric Cancer (GC)Radiotherapy+2 more
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University 40